Literature DB >> 21357903

Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.

Paul H Axelsen1, Hiroaki Komatsu, Ian V J Murray.   

Abstract

Amyloid β proteins and oxidative stress are believed to have central roles in the development of Alzheimer's disease. Lipid membranes are among the most vulnerable cellular components to oxidative stress, and membranes in susceptible regions of the brain are compositionally distinct from those in other tissues. This review considers the evidence that membranes are either a source of neurotoxic lipid oxidation products or the target of pathogenic processes involving amyloid β proteins that cause permeability changes or ion channel formation. Progress toward a comprehensive theory of Alzheimer's disease pathogenesis is discussed in which lipid membranes assume both roles and promote the conversion of monomeric amyloid β proteins into fibrils, the pathognomonic histopathological lesion of the disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357903     DOI: 10.1152/physiol.00024.2010

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  45 in total

1.  Intra-membrane oligomerization and extra-membrane oligomerization of amyloid-β peptide are competing processes as a result of distinct patterns of motif interplay.

Authors:  Yi-Jiong Zhang; Jing-Ming Shi; Cai-Juan Bai; Han Wang; Hai-Yun Li; Yi Wu; Shang-Rong Ji
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

2.  Activation of AMP-activated protein kinase in cerebella of Atm-/- mice is attributable to accumulation of reactive oxygen species.

Authors:  Xianghong Kuang; Mingshan Yan; Joanne M Ajmo; Virginia L Scofield; George Stoica; Paul K Y Wong
Journal:  Biochem Biophys Res Commun       Date:  2012-01-10       Impact factor: 3.575

Review 3.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

4.  Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.

Authors:  Kyle J Korshavn; Cristina Satriano; Yuxi Lin; Rongchun Zhang; Mark Dulchavsky; Anirban Bhunia; Magdalena I Ivanova; Young-Ho Lee; Carmelo La Rosa; Mi Hee Lim; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

5.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

6.  Membrane-specific spin trap, 5-dodecylcarbamoyl-5-N-dodecylacetamide-1-pyroline-N-oxide (diC12PO): theoretical, bioorthogonal fluorescence imaging and EPR studies.

Authors:  Colwyn A Headley; Claire N Hoffman; Juliana M Freisen; Yongbin Han; Joseph M Macklin; Jay L Zweier; Antal Rockenbauer; Jeff Kuret; Frederick A Villamena
Journal:  Org Biomol Chem       Date:  2019-07-22       Impact factor: 3.876

Review 7.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

8.  The amyloid precursor protein (APP) family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression-relevance for Alzheimer's disease.

Authors:  Andreas Schrötter; Kathy Pfeiffer; Fouzi El Magraoui; Harald W Platta; Ralf Erdmann; Helmut E Meyer; Rupert Egensperger; Katrin Marcus; Thorsten Müller
Journal:  Mol Cell Proteomics       Date:  2012-08-09       Impact factor: 5.911

Review 9.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 10.  Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.

Authors:  Eugenio Barone; Fabio Di Domenico; D Allan Butterfield
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.